| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/05/2004 | WO2003100541A3 Methods for profiling molecules with an objective function |
| 02/05/2004 | WO2003100390A3 High throughput microbalance and methods of using same |
| 02/05/2004 | WO2003098161A3 Integratable fluid flow and property microsensor assembly |
| 02/05/2004 | WO2003097871A3 Marker molecules associated with lung tumors |
| 02/05/2004 | WO2003097789A3 Farnesyl diphosphate synthase from pseudomonas aeruginosa |
| 02/05/2004 | WO2003095974A3 Collection assembly |
| 02/05/2004 | WO2003093816A3 Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) |
| 02/05/2004 | WO2003093494A3 Apparatus including ion transport detecting structures and methods of use |
| 02/05/2004 | WO2003089925A3 Device based on partially oxidized porous silicon and method for the production thereof |
| 02/05/2004 | WO2003089913A3 Method and apparatus for assessing the integrity of a jewellery setting |
| 02/05/2004 | WO2003089624A3 Fc receptor homolog, reagents, and uses thereof |
| 02/05/2004 | WO2003087829A3 Human papilloma virus detection with dna microarray |
| 02/05/2004 | WO2003087822A3 Sensitive immunochromatographic assay |
| 02/05/2004 | WO2003087818A3 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 02/05/2004 | WO2003087805A3 Method for efficiently computing the mass of modified peptides for mass spectrometry data-based identification |
| 02/05/2004 | WO2003087565A3 Propellant test apparatus and method |
| 02/05/2004 | WO2003087353A3 Purified polypeptides involved in membrane biogenesis |
| 02/05/2004 | WO2003087289A3 Methods for the selection of compounds useful for the treatment of huntington’s disease |
| 02/05/2004 | WO2003086461A3 Use of substances for treating tumors |
| 02/05/2004 | WO2003085406A3 Anti-thrombomodulin autoantibody as a thrombosis marker |
| 02/05/2004 | WO2003085086A9 Motif-grafted hybrid polypeptides and uses thereof |
| 02/05/2004 | WO2003084994A3 Use of biological photoreceptors as directly light-activated ion channels |
| 02/05/2004 | WO2003083484A3 Fluorescence-based mucus assay |
| 02/05/2004 | WO2003083442A3 Life sciences business systems and methods |
| 02/05/2004 | WO2003083038A3 Disruption of the redk gene |
| 02/05/2004 | WO2003082919A3 Ox40r binding agents |
| 02/05/2004 | WO2003082255A3 Use of mob-5 in pain |
| 02/05/2004 | WO2003081234A3 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) |
| 02/05/2004 | WO2003081204A3 Microscale sensor element and related device and method of manufacture |
| 02/05/2004 | WO2003078966A3 Signal amplification by hybrid capture |
| 02/05/2004 | WO2003078962A3 Detection and quantification of modified proteins |
| 02/05/2004 | WO2003077853A3 Immortal porcine cells |
| 02/05/2004 | WO2003076895A3 Method and system for determining genotype from phenotype |
| 02/05/2004 | WO2003076894A3 A rapid immunochemical process for measuring thiopurine methyltransferase reaction products |
| 02/05/2004 | WO2003076651A3 Cancer associated araf1 protein kinase and its uses |
| 02/05/2004 | WO2003069349A3 Method for diagnosis of inflammatory diseases using mrp8/mrp14 |
| 02/05/2004 | WO2003069341A3 Method of diagnosis of inflammatory diseases using calgranulin c |
| 02/05/2004 | WO2003066091A3 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 02/05/2004 | WO2003064593A3 Antigen panels and methods of using the same |
| 02/05/2004 | WO2003062264A3 Functional ligand display |
| 02/05/2004 | WO2003055911A8 Cystine-knot fold protein |
| 02/05/2004 | WO2003054507A3 Nanocrystals |
| 02/05/2004 | WO2003054139B1 Compositions and methods utilizing dna polymerases |
| 02/05/2004 | WO2003051832A3 Histamine h2 receptor and uses |
| 02/05/2004 | WO2003046582A3 CANCER PROGNOSIS USING THYMOSIN β10 (Tβ10) |
| 02/05/2004 | WO2003038437A3 Screening method for active agents which influence nerve cells |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | WO2003028658A3 Oxidative stress in plasma |
| 02/05/2004 | WO2003024386A3 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 02/05/2004 | WO2003020947A3 Mid 9002, a human sulfatase family member and uses therefor |
| 02/05/2004 | WO2003016915A8 Tumor specific oligosaccharide sequences and use thereof |
| 02/05/2004 | WO2003006603A3 Triple polypeptide complexes |
| 02/05/2004 | WO2002100883A3 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 02/05/2004 | WO2002094998A3 Analyzing phosphorylated proteins |
| 02/05/2004 | WO2002094378A3 Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease |
| 02/05/2004 | WO2002092200A8 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media |
| 02/05/2004 | WO2002072776A3 Cell culture system for synthesis of infectious hepatitis c virus |
| 02/05/2004 | WO2002061046A3 Novel nucleic acid and polypeptide molecules |
| 02/05/2004 | WO2002059373A3 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 02/05/2004 | WO2002018632A3 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 02/05/2004 | US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040025196 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 02/05/2004 | US20040024543 Methods and systems for analyzing complex biological systems |
| 02/05/2004 | US20040024535 Relational database and system for storing information relating to biomolecular sequences and reagents |
| 02/05/2004 | US20040024534 Process of creating an index for diagnosis or prognosis purpose |
| 02/05/2004 | US20040024533 Method for node mapping, network visualizing and screening |
| 02/05/2004 | US20040024531 Structural unit analysis |
| 02/05/2004 | US20040024293 Methods and systems for analyzing complex biological systems |
| 02/05/2004 | US20040024065 Novel metabolic targets and markers |
| 02/05/2004 | US20040024064 Determining risk for developing a fat metabolism disorder by comparing a sample Gs alpha expression level with that of the normal level; treating the disorder with a nucleic acid that codes a Gs alpha protein; prognosis; diagnosis; |
| 02/05/2004 | US20040024050 Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation |
| 02/05/2004 | US20040023931 Method for maintaining a healthy bone structure by administering to a patient a bone health promoting effective amount of a medicament containing 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic |
| 02/05/2004 | US20040023907 Infection model |
| 02/05/2004 | US20040023877 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 02/05/2004 | US20040023870 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins |
| 02/05/2004 | US20040023865 Polypeptides that contain at least one antigenic portion of a B. microti antigen and DNA sequences encoding such polypeptides. Antigenic epitopes of such antigens are also provided, together with pharmaceutical compositions and |
| 02/05/2004 | US20040023863 Multi-tier approach to the administration of growth factor proteins in the treatment of heart disease. Also disclosed is a method to evaluate the effectiveness of the administration of growth factor proteins comprising the clinical assay of |
| 02/05/2004 | US20040023862 Newly identified uses of BRS3 polypeptides and polynucleotides encoding such polypeptides, to their use in therapy of ischemia, of neurodegenerative diseases, of memory and attention disorders, and in identifying compounds which may be |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040023846 Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith |
| 02/05/2004 | US20040023845 Assay that measures receptor residence time of a ligand on its receptor in vitro for the identification of a ligand for that receptor predicted to be efficacious in vivo in the treatment of a disease that responds to modulation of that receptor's |
| 02/05/2004 | US20040023841 Method for rapid screening of formulations for drug delivery, which uses a high throughput array to screen multiple samples. This method monitors the depletion of a test substance from a donor well, the migration of the substance |
| 02/05/2004 | US20040023595 H2 doped w03, ultra-fast, high-sensitivity hydrogen sensors |
| 02/05/2004 | US20040023415 Biospecific contrast agents |
| 02/05/2004 | US20040023413 Microscale immobilization of molecules using a hydrogel and methods of use thereof |
| 02/05/2004 | US20040023412 Kit to determining the binding capability of ligands to an analyte; microfluidics |
| 02/05/2004 | US20040023409 Reagents and methods that afford direct attachment of the acridine dye reporter to either the N-terminus or C-terminus of a synthetic or recombinant peptide or protein and their derivatives in a site-specific manner |
| 02/05/2004 | US20040023408 Site-specific labelling of proteins using cyanine dye reporters |
| 02/05/2004 | US20040023404 Analyzers and methods for analyzing analytes |
| 02/05/2004 | US20040023402 Agent for detecting malondialdehyde, method of making the same, and test kit for use thereof |
| 02/05/2004 | US20040023401 Visualizing polypeptide on gels via sensitization of polypeptide with acidic organic dyes; colorimetric analysis |
| 02/05/2004 | US20040023400 Test piece for assaying high density lipoprotein (hdl) cholesterol |
| 02/05/2004 | US20040023399 Using soluble dyes to visualizing and measure parameters associated with packaged erythrocytes in blood sample; colorimetric analysis |
| 02/05/2004 | US20040023396 Ring or disk resonator photonic biosensor and its use |
| 02/05/2004 | US20040023391 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 02/05/2004 | US20040023386 Modulation of nitric oxide synthase by PKC |
| 02/05/2004 | US20040023377 Culturing lymphocyte population for diagnosis, prevention and treatment of allergies, autoimmune and graft rejection disorders |
| 02/05/2004 | US20040023375 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 02/05/2004 | US20040023373 Novel mucosal vascular addressins |
| 02/05/2004 | US20040023369 Apparatus comprising immobilized hydrolase which utilizes colorimetric and calorimetric analysis for monitoring and detecting toxic, hazardous and nerve blocking agents |